374Water Inc. — Filing Summary
Filing and period: The supplied filing is a Form 10-K for the fiscal year ended December 31, 2011, filed April 16, 2012. The filing identifies the registrant as PowerVerde, Inc., formerly Vyrex Corporation; it does not identify 374Water Inc. The company was a development-stage renewable-energy technology business focused on pressure-driven electric-generation systems using waste heat, solar thermal energy, geothermal energy, biomass, or natural-gas pipeline pressure.
Financial Performance and Position
| Metric | 2011 | 2010 | Change |
|---|---|---|---|
| Revenue | $193,391 | $33,842 | +471% |
| Gross profit | $56,466 | $33,842 | +67% |
| Gross margin | 29.2% | 100.0% | Lower due to cost of the system sold |
| Research and development | $994,619 | $169,665 | +486% |
| General and administrative | $1,628,739 | $198,900 | +719% |
| Loss from operations | $(2,566,892) | $(334,723) | Materially higher loss |
| Net loss | $(2,553,465) | $(308,352) | +728% loss |
| Basic and diluted loss per share | $(0.10) | $(0.01) | Higher loss per share |
| Cash flow from operations | $(1,469,173) | $(298,273) | Greater cash use |
| Cash and cash equivalents | $7,530 | $15,646 | Down $8,116 |
| Working capital | $(128,599) | $(132,895) | Small improvement |
Revenue consisted primarily of a $130,000 discounted Liberator system sale to Newton, $7,221 of other Newton revenue, and $56,170 of biotechnology intellectual-property licensing fees. The company had generated no material recurring product revenue and remained unprofitable since inception.
Total assets were $66,515, including $50,706 of current assets. Total liabilities were $360,292, including $179,304 of accounts payable and accrued expenses and a $180,988 long-term related-party note payable. Stockholders’ deficiency was $293,777. The filing does not provide a clear conventional EBITDA measure.
Financing activities provided $1,472,250 of cash in 2011, principally from $1.5 million of private-placement equity proceeds, partially offset by $150,000 of stock-issuance costs. The company reported $1,500,000 of gross equity proceeds during the first half of 2011. It stated that nearly all funds had been spent by year-end and that, after most first-quarter 2012 funds were spent, it had only approximately one month of operating cash remaining.
Material Changes Versus the Prior Period
- Revenue increased from $33,842 to $193,391, primarily because of the first Liberator system sale to Newton.
- Research and development spending rose by $824,954, while general and administrative spending rose by $1,429,839, reflecting expanded development, testing, staffing, travel, and commercialization efforts.
- Net loss increased from $308,352 to $2,553,465.
- Operating cash use increased from $298,273 to $1,469,173.
- The company issued 2,000,000 common shares for $1.5 million in gross proceeds and issued substantial warrants and stock options. At year-end, 4,294,999 warrants and 1,750,000 options were outstanding.
- George Konrad surrendered 4,500,000 shares to treasury in exchange for a $200,000 interest-free related-party obligation, recorded at $180,988 after discounting.
- The company entered into a definitive European license agreement with Newton, granting exclusive manufacturing and distribution rights in the 27 EU countries for 10 years, subject to minimum sales and other conditions. PowerVerde is entitled to a 20% royalty on Newton’s gross system sales.
- The company signed a binding letter of intent to acquire Cornerstone Conservation Group. The acquisition closed March 30, 2012, after the reporting date, for restricted shares and warrants and added combined cooling, heating, and power and geothermal technology.
Guidance, Outlook, Risks, and Unusual Items
Management planned to focus in 2012 on working with Newton and Autonational to commercialize waste-heat and solar systems in Europe. It targeted completion of development and testing by summer 2012 and a market-ready system by year-end 2012, while acknowledging that these milestones might not be achieved. The 100kW natural-gas pipeline system’s first commercial beta test was expected to be delayed until 2013.
- The independent auditor stated that recurring losses, negative operating cash flows, current liabilities exceeding current assets, and uncertainty regarding additional financing raised substantial doubt about the company’s ability to continue as a going concern.
- Management stated that substantial additional capital had to be raised promptly and that failure to obtain financing could force the company to cease operations.
- Commercialization remained unproven: the company had sold only one system, at a discount, and had no assurance that Newton would meet minimum sales requirements or that material royalties would be generated.
- The business faced significant technology, manufacturing, customer-acceptance, regulatory, intellectual-property, supplier, insurance, competition, energy-price, and government-incentive risks.
- The company’s stock traded on the OTCBB, was thinly traded, and was subject to penny-stock rules. No dividends were planned.
- Stock-based compensation and warrant expense were significant unusual noncash items: $466,907 of stock-option compensation and $612,150 of warrant expense were recorded in 2011.
- Related-party transactions included payments to entities controlled by company officers, the related-party note payable, and $57,415 paid to the CFO’s accounting firm for financial consulting and accounting services.
- The company reported effective disclosure controls and effective internal control over financial reporting as of December 31, 2011; the auditor was not required to provide an internal-control attestation.
Investor Verification Items
- Confirm the issuer identity and corporate history, because the supplied filing is for PowerVerde, Inc., not 374Water Inc.
- Review the audited financial statements and going-concern disclosure, particularly the $7,530 cash balance, $360,292 total liabilities, and $293,777 stockholders’ deficiency.
- Verify the terms, enforceability, minimum-sales requirements, and actual performance of the Newton European license and royalty arrangement.
- Assess whether the post-year-end Cornerstone acquisition generated measurable operating or financial benefits and determine the dilution from issued shares and warrants.
- Reconcile the company’s share count, treasury shares, outstanding warrants, and options, including potential future dilution.
- Evaluate the company’s dependence on additional financing and whether subsequent financing was sufficient to address the disclosed one-month liquidity runway.
- Review related-party obligations, compensation arrangements, facility leases, and the $200,000 payment obligation to ARD.